ChemicalBook--->CAS DataBase List--->1865733-40-9

1865733-40-9

1865733-40-9 Structure

1865733-40-9 Structure
IdentificationBack Directory
[Name]

Capmatinib hydrochloride
[CAS]

1865733-40-9
[Synonyms]

Capmatinib hydrochloride
Capmatinib hydrochloride Hydrate
[Molecular Formula]

C23H17FN6O.2HCl.H2O
[MOL File]

1865733-40-9.mol
[Molecular Weight]

466.9
Chemical PropertiesBack Directory
[form ]

Solid
[color ]

White to light yellow
[InChIKey]

XCHIKTXPDQTRMI-UHFFFAOYSA-N
[SMILES]

C(C1C=CC2N=CC=CC=2C=1)C1=CN=C2N=CC(C3C=CC(C(=O)NC)=C(F)C=3)=NN12.Cl.O
Hazard InformationBack Directory
[Description]

Capmatinib dihydrochloride hydrate is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor (IC50=0.13 nM). Capmatinib dihydrochloride hydrate can inhibit phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Capmatinib dihydrochloride hydrate potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis. Antitumor activity. Good efficacy in the treatment of non-small cell lung cancer (NSCLC) caused by MET 14 exon skipping mutations. Capmatinib dihydrochloride hydrate is largely metabolized by CYP3A4 and aldehyde oxidase[1-3].
[Origin]

Capmatinib was first reported in 2011 by Liu et al., who showed that in both in vivo and in vitro mice studies using human cell lines, capmatinib had a 10,000-fold selectivity for c-met over a large panel of human kinase. They showed that capmatinib can block the c-MET phosphorylation and activation of downstream targets, including HGF. They further showed that activated c-met upregulates cancer-promoting EGFR and HER-3 pathways. Baltschukat et al. further investigated capmatinib in NSCLC[4].
[Mechanism of action]

Tabrecta (capmatinib) is a kinase inhibitor that targets MET, including the mutant variant produced by exon 14 skipping. MET exon 14 skipping results in a protein with a missing regulatory domain that reduces its negative regulation, leading to increased downstream MET signaling.
[Toxicity evaluation]

Effects During Pregnancy and Lactation No information is available on the clinical use of capmatinib during breastfeeding. Because capmatinib is 96% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during capmatinib therapy and for 1 week after the last dose.
[References]

[1] HSUROBERT NagasakaMisako BenjaminDavid J. The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative Review.[J]. Cancers, 2023. DOI:10.3390/cancers15143561.
[2] LIUXIANGDONG. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3.[J]. Clinical Cancer Research, 2011. DOI:10.1158/1078-0432.CCR-11-1157.
[3] BALTSCHUKATSABRINA. Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation.[J]. Clinical Cancer Research, 2019. DOI:10.1158/1078-0432.CCR-18-2814.
1865733-40-9 suppliers list
Company Name: Jinan Million Pharmaceutical Co., Ltd
Tel: 0531-68659554 +8613031714605 , +8613031714605
Website: https://www.millionpharm.com/
Company Name: BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Tel: +86-18600796368 +86-18600796368 , +86-18600796368
Website: http://www.sjar-tech.com/
Company Name: Fuzhou Lista Biotechnology Co.,Ltd
Tel:
Website:
Company Name: Zison Pharmaceutical (Shandong) Co., Ltd.
Tel: +86-0086-531-88259693 +86-18660188356 , +86-18660188356
Website: https://www.zisonpharm.com/
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000 , +1-00000000000
Website: https://www.targetmol.com/
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105 , +1-13798911105
Website: https://www.invivochem.com/
Company Name: Beijing Mesochem Technology Co.,Ltd
Tel: +8613651027935 , +8613651027935
Website: http://www.aiwxo.com/manufacturer/beijing-mesochem-technology-10628/
Company Name: TargetMol Chemicals Inc.
Tel:
Website: www.targetmol.com/
Company Name: SUZHOU SENFEIDA CHEMICAL CO.,LTD
Tel: +86-0512-83500002 +8615195660023 , +8615195660023
Website:
Company Name: Wuhan Topule Biopharmaceutical Co., Ltd
Tel: +8618327326525 , +8618327326525
Website: topule.com/
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Website: www.aladdinsci.com/
Company Name: Wuhan Jingkang en Biomedical Technology Co., Ltd
Tel: +8613720134139 , +8613720134139
Website: http://www.jknbiochem.com/
Company Name: Taizhou Creating Bio-pharm co., ltd.
Tel: +8613586099526 , +8613586099526
Website: www.creatingchemical.com/
Company Name: Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd.
Tel: +86-0311-67591193 +8615933619867 , +8615933619867
Website: www.dingminpharmaceutical.com
Company Name: Wuhan Circle Star Chem-medical Technology Co.,Ltd
Tel: +undefined13437180835 , +undefined13437180835
Website: www.circlestar-chem.com/
Company Name: Suzhou Ryan Pharmaceutical Technology Co., Ltd.  Gold
Tel: 0512-68780025 18962125825
Website: http://www.ryanchem.com
Company Name: Shanghai Hope Chem Co., Ltd.,  Gold
Tel: +21-18501659228 18501659228
Website: http://www.hope-chem.com
Company Name: Suzhou Albertchem Co.,Ltd.  Gold
Tel: 0512-88968486 18012631750
Website: http://www.albertchemical.com
Tags:1865733-40-9 Related Product Information

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept